Foundation Strong in the Spirit, 60 Sienkiewicza St., 90-058 Łódź, Poland.
Department of Hygiene and Epidemiology, Collegium Medicum, University of Zielona Góra, 28 Zyty St., 65-046 Zielona Góra, Poland.
Genes (Basel). 2024 Feb 26;15(3):299. doi: 10.3390/genes15030299.
Gambling Disorder (GD) is characterised by a harmful, enduring, and recurrent involvement in betting-related behaviours. Therefore, GD shares similar biological mechanisms and symptoms to substance use disorders (SUD). Therefore, in this study, we chose the behavioural addictions group. During the examination and recruitment to the study, it turned out that all the people undergoing treatment for gambling addiction were also addicted to amphetamines, which is consistent with the biological mechanism related to cerebral neurotransmission. The aim of the study was to investigate the association of the gene polymorphism with behavioral addiction. The study group consisted of 307 participants: 107 men with gambling disorder and amphetamine dependency (mean age = 27.51, SD = 5.25) and 200 non-addicted, nor dependent, free from neuro-psychiatric disorders control group men (mean age = 20.20, SD = 4.51). Both groups were subjected to psychometric evaluation using the State-Trait Anxiety Inventory and the NEO Five-Factor Personality Inventory. Genomic DNA was extracted from venous blood following standard protocols. Determination of the rs4680 polymorphism in the gene was performed using the real-time PCR technique. Statistically significant differences in the frequency of rs4680 genotypes were found in the tested sample of subjects compared with the control group ( = 0.03543). Subjects with gambling disorder and amphetamine use disorder compared to the control group obtained higher scores in the assessment of the STAI trait scale ( = 0.0019), state scale ( < 0.0000), and NEO-FFI Neuroticism scale ( < 0.0000). Significantly lower results were obtained for the NEO-FFI Agreeability scale ( < 0.0000). Additionally, a significant statistical impact of gambling disorder and amphetamine use disorder, and the rs4680 genotype was demonstrated for the score of the STAI trait ( = 0.0351) and state ( = 0.0343) and the NEO-FFI Conscientiousness scale ( = 0.0018). We conclude that and its polymorphic variant influence the development of addiction. Still, considering its multifactorial and polygenic nature, it should be combined with other factors such as personality.
赌博障碍(GD)的特征是与赌博相关的行为存在有害的、持久的和反复发生的参与。因此,GD 与物质使用障碍(SUD)具有相似的生物学机制和症状。因此,在这项研究中,我们选择了行为成瘾组。在检查和招募研究对象的过程中,事实证明,所有接受赌博成瘾治疗的人也对安非他命上瘾,这与与大脑神经递质相关的生物学机制一致。本研究的目的是探讨基因多态性与行为成瘾的关系。研究组包括 307 名参与者:107 名男性赌博障碍和安非他命依赖症患者(平均年龄=27.51,SD=5.25)和 200 名非成瘾、非依赖、无神经精神障碍的对照组男性(平均年龄=20.20,SD=4.51)。两组均采用状态-特质焦虑量表和 NEO 五因素人格量表进行心理测量评估。采用标准方案从静脉血中提取基因组 DNA。采用实时 PCR 技术测定 基因 rs4680 多态性。与对照组相比,在测试的受试者样本中发现 rs4680 基因型的频率存在统计学显著差异(=0.03543)。与对照组相比,赌博障碍和安非他命使用障碍患者在 STAI 特质量表(=0.0019)、状态量表(<0.0000)和 NEO-FFI 神经质量表(<0.0000)的评估中得分更高。NEO-FFI 宜人性量表的得分显著降低(<0.0000)。此外,还证明了赌博障碍和安非他命使用障碍以及 rs4680 基因型对 STAI 特质(=0.0351)和状态(=0.0343)以及 NEO-FFI 尽责性量表(=0.0018)评分有显著的统计学影响。我们得出结论,基因及其多态性变体影响成瘾的发展。然而,考虑到其多因素和多基因性质,它应该与其他因素(如人格)相结合。